NuCana (NCNA) Other Non Operating Income (2017 - 2025)
NuCana's (NCNA) quarterly Other Non Operating Income came in at $57197.1 in Q4 2025, down 89.8% year-on-year from $560890.3 in Q4 2024, and down 57.61% quarter-over-quarter from $134936.2 in Q3 2025.
NuCana (NCNA) Other Non Operating Income (2017 - 2025) Analysis & Trends
NuCana has disclosed Other Non Operating Income across 9 years of filings, most recently posting $57197.1 for Q4 2025.
- Other Non Operating Income for Q4 2025 came in at $57197.1, down 89.8% year-over-year; the trailing twelve-month figure through Dec 2025 was -$151654.4 (down 152.21% YoY), and the FY2025 annual result was $255791.0, down 12.62% from the prior year.
- Other Non Operating Income came in at $57197.1 for Q4 2025 at NuCana, down from $134936.2 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $3.9 million in Q2 2022 to a low of -$2.6 million in Q4 2022.
- The 5-year median for Other Non Operating Income is -$122878.4 (2021), against an average of $112444.4.
- Peak annual rise in Other Non Operating Income reached 2643.39% in 2022, while the deepest fall reached 779.17% in 2022.
- NuCana's Other Non Operating Income stood at -$297910.3 in 2021, then plunged by 779.17% to -$2.6 million in 2022, then jumped by 78.25% to -$569688.7 in 2023, then jumped by 198.46% to $560890.3 in 2024, then sank by 89.8% to $57197.1 in 2025.
- The last three Other Non Operating Income figures came in at $57197.1 (Q4 2025), $134936.2 (Q3 2025), and -$269477.2 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | NuCana | 29.13 Bn | 29.13 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 57,197.15 |
| Sep 30, 2025 | 134,936.21 |
| Jun 30, 2025 | -269,477.23 |
| Mar 31, 2025 | -74,310.53 |
| Dec 31, 2024 | 560,890.30 |
| Sep 30, 2024 | -297,539.74 |
| Jun 30, 2024 | -93,404.34 |
| Mar 31, 2024 | 120,509.23 |
| Dec 31, 2023 | -569,688.72 |
| Sep 30, 2023 | 711,876.85 |
| Jun 30, 2023 | -705,768.82 |
| Mar 31, 2023 | -844,779.12 |
| Dec 31, 2022 | -2.62 Mn |
| Sep 30, 2022 | 3.43 Mn |
| Jun 30, 2022 | 3.87 Mn |
| Mar 31, 2022 | -1.54 Mn |
| Dec 31, 2021 | -297,910.34 |
| Sep 30, 2021 | 1.76 Mn |
| Jun 30, 2021 | -152,352.38 |
| Mar 31, 2021 | -933,529.36 |